0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover0.00%IV-73.53%PremiumDec 20, 2024Expiry Date7.42Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma1.35Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Paragon 28 Stock Discussion
Paragon 28 Launches the Phantom® Fibula Nail System for Less Invasive Fracture Repair
Paragon 28 (NYSE: FNA) has launched the Phantom® Fibula Nail System, offering surgeons a less invasive option for treating ankle fractures. This system has shown fewer soft tissue complications, implant removals, and fracture nonunion compared to traditional plate and screw fixation. The system includes innovative features such as:
- Instrumentation for anatomic reduction and proper im...
Paragon 28 Introduces a Novel Right-Angle Drill for the APEX 3D™ Total Ankle Replacement System
Paragon 28 (NYSE: FNA) has introduced a novel Right-Angle Drill for its APEX 3D™ Total Ankle Replacement System. This new tool is designed to improve tibia preparation before implanting the APEX 3D™ tibia implant. The drill uses a linear guide to precisely create vertical holes in the tibia, ensuring ideal peg placement and a stable implant interface.
This addition is part of...
On the last trading day, there were five traditional IPO filed, while one new stock officially was listed for trading.
Medical device company Paragon 28 started trading yesterday. It soared 16.94% in its NYSE debut and was valued at $1.41 billion.
Cloud-based expense management software platform $Expensify (EXFY.US)$ , based in Portland, Oregon, helps the smallest to the largest businesses simplify the way they manage money.
Since its founding in 2008, it has added over 10 million members to the community, and processed and automated over 1.1 billion expense transactions on the platform.
For the quarter ended June 30, 2021, an average of 639,000 paid members across 53,000 companies and over 200 countries and territories used Expensify to make money easy.
$Paragon 28 (FNA.US)$ , founded in 2010, is a medical device company exclusively focused on the foot and ankle orthopedic market.
It provides a comprehensive portfolio of solutions that includes surgical implants and disposables, as well as surgical instrumentation. The company's suite of surgical solutions comprises 72 product systems, including approximately 8,700 SKUs to help fit the specific needs of each patient and procedure.
It designs each products with the goal of improving outcomes, reducing ailment recurrence and complication rates, and making the procedures simpler, consistent and reproducible.
$TaskUs (TASK.US)$ is a digital outsourcer, focused on serving high-growth technology companies to represent, protect and grow their brands.
It provides customer support services to fast-growing tech companies including Uber, Netflix, Coinbase and Zoom.
Employees are spread across eight countries, and TaskUs dedicates hundreds or even thousands of staffers to its top clients so it can handle all their support-related issues.
Revenue climbed 33% last year to $478 million, and TaskUs is profitable, showing annual net income of $34.5 million last year.
As of October 17th, it has a listed-to-date return of181.57%, with a market cap of $6.30billion.
GitLab IPO: 5 things to know about the $8 billion valued all-remote software company
$Gitlab (GTLB.US)$ $AvidXchange (AVDX.US)$ $Augmedix (AUGX.US)$ $Cingulate (CING.US)$ $Lucid Diagnostics (LUCD.US)$ $IHS Holding (IHS.US)$ $Paragon 28 (FNA.US)$
No comment yet